Last reviewed · How we verify

Duration of DAPT — Competitive Intelligence Brief

Duration of DAPT (Duration of DAPT) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Cardiovascular.

marketed Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Duration of DAPT (Duration of DAPT) — Samsung Medical Center. Duration of DAPT refers to the optimal length of time a patient should remain on dual antiplatelet therapy (typically aspirin plus a P2Y12 inhibitor) following percutaneous coronary intervention.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Duration of DAPT TARGET Duration of DAPT Samsung Medical Center marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Duration of DAPT — Competitive Intelligence Brief. https://druglandscape.com/ci/duration-of-dapt. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: